Lipoprotein(a), tobacco use, and risk of coronary heart disease

被引：0

作者：

Serrano, M ^{[1
]}

de Irala, J

Palacios, M

机构：

[1] Univ Navarra, E-31080 Pamplona, Spain

[2] Serv Navarro Salud, Pamplona, Spain

来源：

INTERNATIONAL JOURNAL OF CARDIOLOGY | 2000年 / 74卷 / 2-3期

关键词：

lipoprotein(a); coronary heart disease; tobacco; cardiovascular risk;

D O I：

10.1016/S0167-5273(00)00271-0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：233 / 234

页数：2

相关论文

共 5 条

[1] Therapy for lowering lipoprotein(a) levels
Angelin, B
[J]. CURRENT OPINION IN LIPIDOLOGY, 1997, 8 (06) : 337 - 341
[2] APOLIPOPROTEIN(A) GENE ACCOUNTS FOR GREATER THAN 90-PERCENT OF THE VARIATION IN PLASMA LIPOPROTEIN(A) CONCENTRATIONS
BOERWINKLE, E
LEFFERT, CC
LIN, JP
LACKNER, C
CHIESA, G
HOBBS, HH
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (01) : 52 - 60
[3] STRUCTURE AND METABOLISM OF LIPOPROTEIN (A)
MARCOVINA, SM
MORRISETT, JD
[J]. CURRENT OPINION IN LIPIDOLOGY, 1995, 6 (03) : 136 - 145
[4] LIPOPROTEIN (A) - HETEROGENEITY AND BIOLOGICAL RELEVANCE
SCANU, AM
FLESS, GM
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (06) : 1709 - 1715
[5] A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in stanford five-city project participants
Wild, SH
Fortmann, SP
Marcovina, SM
[J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (02) : 239 - 245